← Back to HBIO

Harvard Bioscience, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 11/08/2026Mar 2026Filed 12/05/2026Sep 2025Filed 06/11/2025Jun 2025Filed 11/08/2026Mar 2025Filed 12/05/2026Sep 2024Filed 06/11/2025Jun 2024Filed 11/08/2025Mar 2024Filed 12/05/2025
$23$21$21$20$22$22$23$25
−$2.9−$3.4−$1.2−$2.3−$50−$4.8−$2.9−$4.7
−$0.64−$0.77−$0.03−$0.52−$11.42−$0.11−$0.07−$0.11
4.54.5454.44.4444343

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.